Senior corporate finance executive and investor-relations specialist with experience in cross-border M&A, capital markets and strategic finance. Debra Pladsen led treasury, investor communications and transaction execution at public and private companies, advising boards on capital structure, IPO readiness and liquidity management. Known for bridging operating teams and institutional investors, she has worked across technology and healthcare sectors and holds an MBA and BA in finance, positioning her for CFO/advisory roles or board-level oversight.
Senior corporate finance executive and investor-relations specialist with experience in cross-border M&A, capital markets and strategic finance. Debra Pladsen led treasury, investor communications and transaction execution at public and private companies, advising boards on capital structure, IPO readiness and liquidity management. Known for bridging operating teams and institutional investors, she has worked across technology and healthcare sectors and holds an MBA and BA in finance, positioning her for CFO/advisory roles or board-level oversight.
Seasoned corporate finance executive who prioritizes capital efficiency, liquidity management and investor transparency. Focuses on disciplined capital allocation that balances strategic M&A, IPO readiness and working-capital optimization to support durable growth. Employs a market-oriented lens bridging operating teams and institutional investors, favoring technology and healthcare opportunities where operational improvements and clear governance unlock value. Time horizon is medium-to-long; risk framework emphasizes stress-tested capital structures, transparent communication and board-aligned decision making.
Seasoned corporate finance executive who prioritizes capital efficiency, liquidity management and investor transparency. Focuses on disciplined capital allocation that balances strategic M&A, IPO readiness and working-capital optimization to support durable growth. Employs a market-oriented lens bridging operating teams and institutional investors, favoring technology and healthcare opportunities where operational improvements and clear governance unlock value. Time horizon is medium-to-long; risk framework emphasizes stress-tested capital structures, transparent communication and board-aligned decision making.
| Trades 415 | Longs Won 331/415 79% | Profit Factor 22.16 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $294,412.75 |
| Average Win $97,287.85 | Best Trade (Jul 10) $4.27M | Sharpe Ratio -16.31 |
| Average Loss -$17,300.34 | Worst Trade (Jul 17) -$632,875.62 | Z-Score 20.65 (100%) |
| Commissions $0 | Avg. Trade Length 10m 2w | Expectancy $74,094.1 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,850 | 7,965 | 7,080 | 6,195 | 5,310 | 4,425 | 3,540 | 2,655 | 1,770 | 885 |